Determinants of cancer care delays in Kinshasa, Democratic Republic of the Congo (DRC)
Background Cancer outcomes in sub-Saharan Africa are driven by delayed diagnosis and treatment initiation. We evaluated the magnitude and determinants of diagnostic and treatment delays among cancer patients in Kinshasa, Democratic Republic of the Congo (DRC). Methods We conducted a hospital-based cross-sectional study of 460 adults with confirmed cancer at Nganda Hospital Center in Kinshasa, DRC. Two outcomes were assessed: delay from symptom onset to diagnosis and delay from diagnosis to treatment initiation. Log-normal regression models were fitted for each outcome to estimate adjusted geometric mean ratios (aGMRs) and 95% confidence intervals (CIs). Covariates included demographic, socioeconomic, clinical, behavioral, and stigma-related factors. Results The median age was 55 years, and 76.2% of participants were women. Overall, 55.0% of participants experienced symptom-to-diagnosis delays > 6 months, and 49.4% experienced diagnosis-to-treatment delays > 3 months. Age ≥ 65 years was associated with longer diagnostic delay (aGMR 1.55, 95% CI 1.03–2.31) and age 50–64 years with longer treatment delay (1.51, 1.07–2.14). No work outside the household in the past 7 days was associated with both diagnostic delay (1.68, 1.15–2.47) and treatment delay (2.27, 1.54–3.33). Longer diagnostic delay was additionally associated with informal trading (1.99, 1.21–3.28) and shared taxi or motorbike transport (1.92, 1.25–2.94), while high cancer-stereotype stigma was associated with longer treatment delay (1.56, 1.04–2.34). Associations with hepatitis B infection (diagnostic delay 1.88, 1.06–3.34; treatment delay 2.42, 1.15–5.11) and smoking (diagnostic delay 2.25, 1.03–4.91) were based on small numbers ( n = 14 each) and were imprecisely estimated. Conclusions Substantial delays exist across the DRC cancer care continuum and are associated with markers of socioeconomic vulnerability, transport barriers and cancer-related stigma. These findings highlight the need for integrated interventions to improve timely diagnosis and treatment initiation, including strengthening financial protection, decentralizing cancer services, and reducing stigma in cancer care.
Authors
- Pélagie Babakazo (ORCID: https://orcid.org/0000-0001-5561-696X)
- Fidéle Lumande Kasindi
- Kavita Sehrawat
- Ali Alisho
- Jean Claude Dusingize (ORCID: https://orcid.org/0000-0001-5721-100X)
- Marcel Yotebieng (ORCID: https://orcid.org/0000-0003-2110-2631)
- Natalia Zotova (ORCID: https://orcid.org/0000-0001-5396-8304)
- Ilyass Yessoufou
- Rafi Kabarriti
- Assan Isangu
- on behalf of CA-IeDEA
- Arnold Sulu
Institutions
- Albert Einstein College of Medicine (US)
- University of Kinshasa (CD)
- Ecole de santé publique de Kinshasa (CD)
Publication Details
- Journal
- BMC Cancer
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1186/s12885-026-17405-0
- Citations
- 1
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 2.05
Funders
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism
- National Heart, Lung, and Blood Institute
- National Institute on Drug Abuse
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
- Fogarty International Center
- National Institute of Diabetes and Digestive and Kidney Diseases
- U.S. National Library of Medicine